Key patent granted for Regeneus stem cell technology – Proactive Investors Australia
Proactive Investors Australia |
Key patent granted for Regeneus stem cell technology
Proactive Investors Australia Progenza differentiates from other mesenchymal stem cell products due to using adipose MSCs which provide considerable benefits in scalability and costs in the manufacturing process. It has proven capacity to manufacture in excess of 10 million … |
